Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZDHHC11 Activators

ZDHHC11 Activators encompass a variety of chemical compounds that indirectly augment the functional activity of ZDHHC11 through distinct signaling pathways and biochemical processes. Palmitoyl Coenzyme A, the substrate for ZDHHC11's palmitoylation activity, directly enhances its function, as ZDHHC11 transfers palmitoyl groups to target proteins, a crucial post-translational modification. Analogously, 2-Bromopalmitate, by inhibiting protein palmitoylation, necessitates increased ZDHHC11 activity for effective palmitoylation. The role of ZDHHC11 in lipid modification is further emphasized by compounds like Cerulenin and Fumonisin B1, which inhibit fatty acid synthase and ceramide synthase, respectively, thereby shifting cellular dependency to ZDHHC11-mediated palmitoylation for cell signaling. Manumycin A, by inhibiting farnesyltransferase, and Myriocin, by inhibiting serine palmitoyltransferase, similarly elevate ZDHHC11's role in palmitoylation as an alternative lipid modification pathway. Curcumin's modulation of lipid raft composition could affect ZDHHC11's localization and function, considering its role in modifying proteins in these microdomains.

Furthermore, compounds like Forskolin and Nicotinamide indirectly influence ZDHHC11 activity through secondary pathways. Forskolin increases cAMP levels, leading to PKA activation, which may phosphorylate substrates that regulate or interact with ZDHHC11, thus indirectly enhancing its activity. Nicotinamide, by inhibiting sirtuins, affects acylation processes, potentially increasing the functional demand on ZDHHC11-mediated palmitoylation. Additionally, Triciribine and U0126, acting as AKT and MEK inhibitors respectively, affect signaling pathways that intersect with lipid signaling processes where ZDHHC11 operates. Brefeldin A, disrupting the Golgi apparatus, potentially increases reliance on ZDHHC11 for protein palmitoylation in other cellular compartments. Collectively, these activators, through their targeted influence on lipid metabolism and cell signaling pathways, enhance the functional role of ZDHHC11, particularly in the context of protein palmitoylation and cellular signaling dynamics.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP can lead to PKA activation, which may phosphorylate substrates that interact with or regulate ZDHHC11, indirectly enhancing its functional activity.

Cerulenin (synthetic)

17397-89-6sc-200827
sc-200827A
sc-200827B
5 mg
10 mg
50 mg
$161.00
$312.00
$1210.00
9
(1)

Cerulenin inhibits fatty acid synthase, affecting lipid metabolism. This inhibition can increase the reliance on ZDHHC11-mediated palmitoylation for cell signaling, indirectly enhancing ZDHHC11 activity.

Fumonisin B1

116355-83-0sc-201395
sc-201395A
1 mg
5 mg
$200.00
$680.00
18
(1)

Fumonisin B1 inhibits ceramide synthase, altering sphingolipid metabolism. This disruption can modify the lipid environment where ZDHHC11 operates, potentially enhancing its palmitoylation activity.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

Manumycin A is a farnesyltransferase inhibitor, affecting protein prenylation. This can shift cellular dependency to palmitoylation, indirectly enhancing ZDHHC11's role in this process.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin modulates lipid raft composition and signaling, which could affect the localization and function of ZDHHC11, as ZDHHC11 is involved in modifying proteins associated with lipid rafts.

Myriocin (ISP-1)

35891-70-4sc-201397
10 mg
$150.00
8
(2)

Myriocin is a potent inhibitor of serine palmitoyltransferase, impacting sphingolipid synthesis. This alteration in lipid composition could increase the functional demand on ZDHHC11-mediated palmitoylation.

Nicotinamide

98-92-0sc-208096
sc-208096A
sc-208096B
sc-208096C
100 g
250 g
1 kg
5 kg
$44.00
$66.00
$204.00
$831.00
6
(1)

Nicotinamide, as an inhibitor of sirtuins, may affect acylation processes, including palmitoylation. This could indirectly enhance the role of ZDHHC11 in maintaining protein palmitoylation levels.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Triciribine, an AKT inhibitor, affects multiple signaling pathways. By modulating AKT activity, it could influence pathways that regulate or are affected by ZDHHC11-mediated palmitoylation.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts Golgi apparatus function, which could affect protein trafficking and modification processes, potentially increasing reliance on ZDHHC11 for protein palmitoylation in other cellular compartments.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a MEK inhibitor affecting the MAPK/ERK pathway. This pathway can interact with lipid signaling pathways, potentially enhancing the demand for ZDHHC11-mediated palmitoylation in certain signaling contexts.